Cargando…
NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
Pancreatic cancer is one of the carcinomas with the worst prognoses, as shown by its five-year survival rate of 9%. Although there have been new therapeutic innovations, the effectiveness of these therapies is still limited, resulting in pancreatic ductal adenocarcinoma (PDAC) becoming the second le...
Autores principales: | Geismann, Claudia, Schäfer, Heiner, Gundlach, Jan-Paul, Hauser, Charlotte, Egberts, Jan-Hendrik, Schneider, Günter, Arlt, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826905/ https://www.ncbi.nlm.nih.gov/pubmed/31561620 http://dx.doi.org/10.3390/cancers11101445 |
Ejemplares similares
-
NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
por: Geismann, Claudia, et al.
Publicado: (2023) -
TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines
por: Geismann, Claudia, et al.
Publicado: (2018) -
c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells
por: Geismann, C, et al.
Publicado: (2014) -
Do We Really Need Another Special Issue on NF-κB in Cancer and Inflammation?
por: Geismann, Claudia, et al.
Publicado: (2019) -
Get rid of pancreatic cancer by inhibiting garbage disposal?: Comment on “UAE1 Inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer” by Rehemtulla et al
por: Geismann, Claudia, et al.
Publicado: (2020)